Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants-Reference-Cited by-同舟云学术

Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants

Published:2017-08-09 Issue:1 Volume:65 Page:e26736
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Bennett Carolyn M.¹^ORCID,Neunert Cindy²,Grace Rachael F.³,Buchanan George⁴,Imbach Paul⁵,Vesely Sara K.⁶,Kuhne Thomas⁷

Affiliation:

1. Department of Pediatrics; Children's Healthcare of Atlanta, Aflac Cancer and Blood Disorder Center; Emory University School of Medicine; Atlanta Georgia

2. Department of Pediatrics; Columbia University Medical Center; New York New York

3. Department of Pediatric Hematology/Oncology; Dana-Farber Boston Children's Cancer and Blood Disorder Center; Boston Massachusetts

4. Department of Pediatrics; University of Texas Southwestern Medical Center; Dallas Texas

5. Prof. Emeritus of the Medical Faculty; University of Basel; Switzerland

6. Department of Biostatistics and Epidemiology; University of Oklahoma Health Sciences Center; Oklahoma City Oklahoma

7. Division of Oncology/Hematology; University Children's Hospital; Basel Switzerland

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference25 articles.

1. Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura;Neunert;Blood,2008

2. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group;Kuhne;J Pediatr,2003

3. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group;Rodeghiero;Blood,2009

4. The American society of hematology 2011 evidence-based practice guideline for immune thrombocytopenia;Neunert;Blood

5. Age and duration of bleeding symptoms at diagnosis best predict resolution of childhood immune thrombocytopenia at 3, 6, and 12 months;Revel-Vilk;J Pediatr,2013

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective Evaluation of Patients Followed-Up and Treated for Idiopathic Thrombocytopenic Purpura: A 21-Year Single-Center Experience;Atatürk Üniversitesi Tıp Fakültesi Cerrahi Tıp Bilimleri Dergisi;2023-12-30

2. <i>Helicobacter pylori</i> infection in children with immune thrombocytopenia;Pediatric Hematology/Oncology and Immunopathology;2023-09-30

3. A proposal for new definition (s) and management approach to paediatric refractory ITP: Reflections from the Intercontinental ITP Study Group;British Journal of Haematology;2023-08-29

4. The Outcomes and Adverse Drug Patterns of Immunomodulators and Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia Egyptian Patients with Hemorrhage Comorbidity;Pharmaceuticals;2023-06-12

5. Mycophenolate Mofetil Use in Pediatric Immune Thrombocytopenia Refractory to First-line Therapy: a Single-center Experience;Journal of Pediatric Hematology/Oncology;2023-06-05